1. Targeting of nucleo‑cytoplasmic transport factor exportin 1 in malignancy
   Sibel Özdaş et al, 2021, Medicine International CrossRef
2. miR-34a-Mediated Survivin Inhibition Improves the Antitumor Activity of Selinexor in Triple-Negative Breast Cancer
   Silvia Martini et al, 2021, Pharmaceuticals CrossRef
3. Clinicopathological and prognostic significance of XPO1 in solid tumors: meta-analysis and TCGA analysis
   Yang Tan et al, 2023, Expert Review of Molecular Diagnostics CrossRef
4. The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphoma
   Jithma P. Abeykoon et al, 2021, Haematologica CrossRef
5. Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
   Hélène Marijon et al, 2021, Oncotarget CrossRef
6. Protection from Disulfide Stress by Inhibition of Pap1 Nuclear Export in Schizosaccharomyces pombe
   Yan Chen et al, 2018, Genetics CrossRef
7. Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody
   Silvia Martini et al, 2020, Cells CrossRef
8. IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells
   Mayte Guadalupe Cervantes-Badillo et al, 2020, Frontiers in Endocrinology CrossRef